Il Dong Pharmaceutical Co Ltd (249420) — Long-term Investment Intensity

Latest as of December 2019: 1.9%

Il Dong Pharmaceutical Co Ltd (249420) has a Long-term Investment Intensity of 1.9% as of December 2019. Long-term investments of ₩11.58 Billion represent 1.9% of total assets of ₩612.72 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Il Dong Pharmaceutical Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

1.9%
LT Investments / Total Assets

Long-term Investments

₩11.58 Billion
KRW

Total Assets

₩612.72 Billion
KRW

Country

Korea
KO

Il Dong Pharmaceutical Co Ltd Long-term Investment Intensity (2016–2019)

This chart shows how Il Dong Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2016 to 2019. As of December 2019, the intensity stands at 1.9%, reflecting long-term investments of ₩11.58 Billion against total assets of ₩612.72 Billion KRW. For the complete balance sheet picture, see Il Dong Pharmaceutical Co Ltd total assets.

Annual Long-term Investment Intensity for Il Dong Pharmaceutical Co Ltd (2016–2019)

The table below presents the year-by-year Long-term Investment Intensity for Il Dong Pharmaceutical Co Ltd from 2016 to 2019, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Il Dong Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2019 1.9% ₩11.58 Billion ₩612.72 Billion ▲ +0.1 pp
2018 1.8% ₩9.97 Billion ₩564.67 Billion ▲ +0.0 pp
2017 1.8% ₩9.92 Billion ₩564.63 Billion ▲ +1.7 pp
2016 0.0% ₩144.50 Million ₩550.35 Billion
pp = percentage points